American Portfolios Advisors’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14
Closed -$2.41K 3528
2022
Q1
$2.41K Hold
14
﹤0.01% 3181
2021
Q4
$2.27K Buy
+14
New +$2.25K ﹤0.01% 3145
2021
Q2
Sell
-76
Closed -$20.1K 3397
2021
Q1
$20.1K Buy
+76
New +$21.4K ﹤0.01% 2068

Other funds holding AMED

American Portfolios Advisors's AMED Position: Q2 2022 in Review

American Portfolios Advisors sold out of Amedisys (AMED) in Q2 2022, closing a stake of 14 shares — an estimated $2.41K sold.

American Portfolios Advisors first reported a position in AMED in Q1 2021 and held it in 3 quarters. The position peaked at $20.1K in Q1 2021. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • American Portfolios Advisors reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • American Portfolios Advisors sold 14 Amedisys shares in Q2 2022, an estimated $2.41K.
  • American Portfolios Advisors first reported a position in Amedisys in Q1 2021 and held it in 3 quarters.
  • American Portfolios Advisors's Amedisys position peaked at $20.1K in Q1 2021.
  • 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on American Portfolios Advisors's 13F filing for Q2 2022, filed 20 Mar 2023.